Product NDC: | 50419-754 |
Proprietary Name: | Cipro |
Non Proprietary Name: | ciprofloxacin hydrochloride |
Active Ingredient(s): | 500 mg/1 & nbsp; ciprofloxacin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-754 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019537 |
Marketing Category: | NDA |
Start Marketing Date: | 19871022 |
Package NDC: | 50419-754-01 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-754-01) |
NDC Code | 50419-754-01 |
Proprietary Name | Cipro |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-754-01) |
Product NDC | 50419-754 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ciprofloxacin hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19871022 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |